140 related articles for article (PubMed ID: 11137563)
1. Drug resistance does not correlate with resistance to Fas-mediated apoptosis.
Cullen KV; Davey RA; Davey MW
Leuk Res; 2001 Jan; 25(1):69-75. PubMed ID: 11137563
[TBL] [Abstract][Full Text] [Related]
2. The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.
Cullen K; Davey R; Davey M
Cytometry; 2001 Mar; 43(3):189-94. PubMed ID: 11170105
[TBL] [Abstract][Full Text] [Related]
3. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Grech KV; Davey RA; Davey MW
Biochem Pharmacol; 1998 Apr; 55(8):1283-9. PubMed ID: 9719484
[TBL] [Abstract][Full Text] [Related]
4. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
Davey MW; Hargrave RM; Davey RA
Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
[TBL] [Abstract][Full Text] [Related]
5. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.
O'Neill GM; Peters GB; Harvie RM; MacKenzie HB; Henness S; Davey RA
Br J Cancer; 1998 Jun; 77(12):2076-80. PubMed ID: 9649117
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells.
Richardson DS; Allen PD; Kelsey SM; Newland AC
Adv Exp Med Biol; 1999; 457():259-66. PubMed ID: 10500801
[TBL] [Abstract][Full Text] [Related]
7. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
8. Effects of PARP inhibition on drug and Fas-induced apoptosis in leukaemic cells.
Richardson DS; Allen PD; Kelsey SM; Newland AC
Adv Exp Med Biol; 1999; 457():267-79. PubMed ID: 10500802
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.
Wu QL; Wu XP; Liang YJ; Chen LM; Ding Y; Fu LW
World J Gastroenterol; 2005 Jun; 11(23):3544-8. PubMed ID: 15962371
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
[TBL] [Abstract][Full Text] [Related]
11. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).
Notarbartolo M; Cervello M; Dusonchet L; Cusimano A; D'Alessandro N
Cancer Lett; 2002 Jun; 180(1):91-101. PubMed ID: 11911975
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
[TBL] [Abstract][Full Text] [Related]
13. Selection for drug resistance results in resistance to Fas-mediated apoptosis.
Landowski TH; Gleason-Guzman MC; Dalton WS
Blood; 1997 Mar; 89(6):1854-61. PubMed ID: 9058704
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
15. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
[TBL] [Abstract][Full Text] [Related]
16. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
18. A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells.
Turella P; Filomeni G; Dupuis ML; Ciriolo MR; Molinari A; De Maria F; Tombesi M; Cianfriglia M; Federici G; Ricci G; Caccuri AM
J Biol Chem; 2006 Aug; 281(33):23725-32. PubMed ID: 16769721
[TBL] [Abstract][Full Text] [Related]
19. The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1.
Davey RA; Davey MW; Cullen KV; Wells XE; Francis CL; Williams HM; Yang Q; Moghaddam MJ; Widmer F; Whittaker RG
Br J Pharmacol; 2002 Dec; 137(8):1280-6. PubMed ID: 12466237
[TBL] [Abstract][Full Text] [Related]
20. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
